Clinical Trial Results:
A multicentre, open label and subsequent randomised, double blind, placebo controlled phase III study to assess the safety and efficacy of maintenance and extended therapy with subcutaneously administered onercept of subjects with moderate to severe plaque psoriasis who have either responded or partially responded to an initial 12-week induction treatment with onercept.
Summary
|
|
EudraCT number |
2004-000535-29 |
Trial protocol |
SE AT IT DK BE ES |
Global completion date |
01 Jun 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Dec 2016
|
First version publication date |
20 Dec 2016
|
Other versions |
|
Summary report(s) |
2004-000535-29_MS EudraCT Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.